Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, signaling a new build of the page.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page’s revision tag changed from v3.6.0 to v3.6.2, reflecting a minor template/backend update that does not modify the study details.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study page now shows recruitment is closed with 'No longer looking for participants', and new help sections were added to guide users (How to Read a Study Record, Common Questions, How to Join a Study). Additionally, a formatting label changed from 'Intervention / Treatment' to 'Intervention/Treatment' and the page revision is updated to v3.6.0, replacing v3.5.5.SummaryDifference0.3%

- Check34 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, signaling a minor site update; no study content or navigation elements appear to be changed.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This indicates a patch-level update to the page's documentation or content.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page’s technical revision/version tag was updated from v3.5.0 to v3.5.3 without changing the study details.SummaryDifference0.0%

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.